alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32     CERTIFICATION  The undersigned hereby certify
that the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2007 of PHL Variable Insurance Company (the
Company) filed with the Securities and Exchange Commission on the date hereof fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in
all material respects, the financial condition and results of operations of the Company.  /s/ Philip K. Polkinghorn
/s/ Michael E. HaylonName:Philip K.
Polkinghorn
Name:Michael
E. HaylonTitle:President
Title:Executive
Vice President andChief
Financial OfficerDate:November 8, 2007
Date:November 8, 2007  A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required by Section 906, has been provided to PHL Variable
Insurance Company and will be retained by PHL Variable Insurance Company and furnished to the Securities and Exchange Commission or
its staff upon request.
#### Deutsche Bank National Trust Company, Appellant, v Luis Rivas, Respondent, et al., Defendants.

[945 NYS2d 328]—

In an action to foreclose a mortgage, the plaintiff appeals from an order of the Supreme Court, Rockland County (Alfieri, J.), dated March 2, 2011, which granted that branch of the motion of the defendant Luis Rivas which was to dismiss the complaint insofar as asserted against him for lack of standing pursuant to CPLR 3211 (a) (3).

Ordered that the order is reversed, on the law, with costs, and that branch of the motion of the defendant Luis Rivas which was to dismiss the complaint insofar as asserted against him for lack of standing pursuant to CPLR 3211 (a) (3) is denied.

In this action to foreclose a mortgage, the defendant Luis Rivas moved to dismiss the complaint insofar as asserted against him on the ground, among others, that the plaintiff lacked standing to commence the action *{see*CPLR 3211 [a] [3]). The Supreme Court granted that branch of the motion. The plaintiff appeals, and we reverse.

When a plaintiffs standing to commence a foreclosure action is placed in issue by the defendant, it is incumbent upon the plaintiff to establish its standing to be entitled to relief *(see Citimortgage, Inc. v Stosel,*89 AD3d 887, 888 [2011]; *US Bank N.A. v Madero,*80 AD3d 751, 752 [2011]; *US Bank, N.A. v Collymore,*68 AD3d 752, 753 [2009]). A plaintiff establishes its standing in a mortgage foreclosure action by demonstrating *1062that it is both the holder or assignee of the subject mortgage and the holder or assignee of the underlying note, “either by physical delivery or execution of a written assignment prior to the commencement of the action” *(Aurora Loan Servs., LLC v Weisblum,*85 AD3d 95, 108 [2011]). Here, the issue of standing cannot be determined as a matter of law on this record *(see HSBC Mtge. Corp. [USA] v MacPherson,*89 AD3d 1061, 1062 [2011]), because there is a question of fact as to whether the plaintiff was the lawful holder of the note when it commenced the action *(see Mortgage Elec. Registration Sys., Inc. v Coakley,*41 AD3d 674 [2007]; *cf. Bank of N.Y. v Silverberg,*86 AD3d 274, 281-282 [2011]; *TPZ Corp. v Dabbs,*25 AD3d 787, 789 [2006]).

The remaining branches of Rivas’s motion remain pending and undecided *(see Katz v Katz,*68 AD2d 536, 542-543 [1979]). Dillon, J.E, Balkin, Eng and Chambers, JJ., concur.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 359 Agreed to Senate (ATS)]

112th CONGRESS
  2d Session
S. RES. 359

 Commending Alan S. Frumin on his service to the United States Senate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 31, 2012

   Mr. Reid (for himself and Mr. McConnell) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION

 
 Commending Alan S. Frumin on his service to the United States Senate.

Whereas Alan S. Frumin, a native of New Rochelle, New York and graduate of 
        Colgate University and Georgetown University Law Center, began his long 
        career with the Congress in the House of Representatives precedents 
        writing office in April of 1974;
Whereas Alan S. Frumin began work with the Secretary of the Senate's Office of 
        the Senate Parliamentarian on January 1, 1977, serving under eight 
        Majority Leaders;
Whereas Alan S. Frumin served the Senate as its Parliamentarian from 1987 to 
        1995 and from 2001 to 2012 and has been Parliamentarian Emeritus since 
        1997;
Whereas Alan S. Frumin revised the Senate's book on procedure, ``Riddick's 
        Senate Procedure'' and is the only sitting Parliamentarian to have 
        published a compilation of the body's work;
Whereas Alan S. Frumin has shown tremendous dedication to the Senate during his 
        35 years of service;
Whereas Alan S. Frumin has earned the respect and affection of the Senators, 
        their staffs and all of his colleagues for his extensive knowledge of 
        all matters relating to the Senate, his fairness and thoughtfulness;
Whereas Alan S. Frumin now retires from the Senate after 35 years to spend more 
        time with his wife, Jill, and his daughter, Allie; Now, therefore, be it
    Resolved, That the Senate expresses its appreciation to Alan S. 
Frumin and commends him for his lengthy, faithful and outstanding 
service to the Senate.
    Resolved, That the Secretary of the Senate shall transmit a copy of 
this resolution to Alan S. Frumin.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                              48
<SECURITIES>                                         0
<RECEIVABLES>                                   14,418
<ALLOWANCES>                                    (6,068)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 9,019
<PP&E>                                          10,130
<DEPRECIATION>                                  (2,083)
<TOTAL-ASSETS>                                  69,826
<CURRENT-LIABILITIES>                            4,075
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            14
<OTHER-SE>                                      30,903
<TOTAL-LIABILITY-AND-EQUITY>                    69,826
<SALES>                                              0
<TOTAL-REVENUES>                                12,576
<CGS>                                                0
<TOTAL-COSTS>                                   11,918
<OTHER-EXPENSES>                                   (18)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 407
<INCOME-PRETAX>                                    233
<INCOME-TAX>                                        95
<INCOME-CONTINUING>                                138
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       138
<EPS-BASIC>                                      .01
<EPS-DILUTED>                                      .01


</TABLE>
**Exhibit 12.1**

**CERTIFICATIONS PURSUANT TO SECTION 302 OF THE U.S. SARBANES-OXLEY ACT OF 2002**

I, Dionisio Romero, certify that:

1. I have reviewed this annual report on Form 20-F of Credicorp Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

| Dated: June 30, 2006 |                        |
|----------------------|-----------------------------|
|                 |                        |   |
|                 | /s/  DIONISIO   ROMERO |   |
|                 |                             |   |
| Name:                | Dionisio Romero             |   |
| Title:               | Chief Executive Officer     |   |
#### UNITED STATES of America, Plaintiff-Appellee, v. Michael Nicholas TAYLOR, a.k.a Paul Blake, Defendant-Appellant.

No. 11-10492

Non-Argument Calendar.

United States Court of Appeals, Eleventh Circuit.

Sept. 30, 2011.

Anne R. Schultz, Wifredo A. Ferrer, U.S. Attorney, Kathleen M. Salyer, U.S. Attorney’s Office, Miami, FL, John C. McMillan, U.S. Attorney’s Office, West Palm Beach, FL, for Plaintiff-Appellee.

Robin Cindy Rosen-Evans, Federal Public Defender’s Office, West Palm Beach, FL, Kathleen M. Williams, Federal Public Defender, Federal Public Defender’s Office, Miami, FL, for Defendant-Appellant.

Michael Nicholas Taylor, FCI Big Spring — Inmate Mail, Big Spring, TX, for Defendant-Appellant.

Before BARKETT, MARCUS and KRAVITCH, Circuit Judges.

PER CURIAM:

Robin Cindy Rosen-Evans, appointed counsel for Michael Nicholas Taylor in this direct criminal appeal, has moved to withdraw from further representation of the appellant and filed a brief prepared pursuant to *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Because independent examination of the entire record reveals no arguable issues of merit, counsel’s motion to withdraw is GRANTED, and Taylor’s conviction and sentence are AFFIRMED.
[Federal Register Volume 86, Number 146 (Tuesday, August 3, 2021)]
[Notices]
[Page 41854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16509]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; AREA/REAP: Cardiovascular and Respiratory Sciences.
    Date: August 30, 2021.
    Time: 1:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 
20892, 301-435-1744, <a href="/cdn-cgi/l/email-protection#771b1e0f1e1619103714040559191e1f59101801"><span class="__cf_email__" data-cfemail="e98580918088878ea98a9a9bc7878081c78e869f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: July 29, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16509 Filed 8-2-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2019312EN.01004601.xml

| 16.9.2019 | EN | Official Journal of the European Union | C 312/46 |
| --- | --- | --- | --- |

16.9.2019

EN

Official Journal of the European Union

C 312/46

---

Action brought on 29 July 2019 — EC Brand Comércio, Importação e Exportação de Vestuário em Geral v EUIPO (pantys)

(Case T-532/19)

(2019/C 312/38)

Language of the case: English

Parties

Applicant: EC Brand Comércio, Importação e Exportação de Vestuário em Geral LTDA (Sorocaba, Brazil) (represented by: B. Bittner and U. Heinrich, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO

Trade mark at issue: Application for European Union figurative mark pantys– Application for registration No 17 869 310

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 May 2019 in Case R 314/2019-5

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision in so far as it dismissed the appeal regarding the following goods and services:






  — | class 05: hygienic absorbents, sanitary napkins, sanitary towels, incontinence pads; |
| --- | --- | --- |

—

annul the contested decision in so far as it dismissed the appeal regarding the following goods and services:

—

class 05: hygienic absorbents, sanitary napkins, sanitary towels, incontinence pads;

| — | class 35: online retail trade services of women’s sanitary products; |
| --- | --- |

—

class 35: online retail trade services of women’s sanitary products;

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Pleas in law

| — | Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
| --- | --- |

—

Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

| — | Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
| --- | --- |

—

Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

| — | Widely use in the European Union. |
| --- | --- |

—

Widely use in the European Union.

---
Exhibit 23.1

               Consent of Independent Auditors

We consent to the incorporation by reference in 1) the Registration Statement
(Form S-3 No. 333-15329) of Sterling House Corporation and in the related
Prospectus pertaining to the registration of $35,000,000 of 6.75% Convertible
Subordinated Debentures due 2006 and to shares of Common Stock issuable upon
conversion of such debentures and 2) the Registration Statement (Form S-8 No.
333-03687) pertaining to the 1995 Stock Option Plan and Director's Stock Option
Agreements of Sterling House Corporation of our report dated February 10, 1997,
with respect to the consolidated financial statements of Sterling House
Corporation included in the Annual Report (Form 10-K) for the year ended
December 31, 1996.

                                            ERNST & YOUNG LLP



Wichita, Kansas
March 26, 1997
#### The People of the State of New York, Respondent, v Otis Bryant, Appellant.

[942 NYS2d 882] —

Application by the appellant for a writ of error coram nobis' to vacate, on the ground of ineffective assistance of appellate counsel, a decision and order of this Court dated March 22, 2011 *(People v Bryant,*82 AD3d 1114 [2011]), affirming a judgment of the Supreme Court, Queens County, rendered November 10, 2008.

Ordered that the application is denied.

The appellant has failed to establish that he was denied the effective assistance of appellate counsel *(see Jones v Barnes,*463 US 745 [1983]; *People v Stultz,*2 NY3d 277 [2004]). Mastro, A.P.J., Dillon, Florio and Hall, JJ., concur.
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-END>                               DEC-31-1997
<CASH>                                        470,793    
<INT-BEARING-DEPOSITS>                      4,702,277
<FED-FUNDS-SOLD>                                    0
<TRADING-ASSETS>                                    0
<INVESTMENTS-HELD-FOR-SALE>                   485,856
<INVESTMENTS-CARRYING>                      2,988,012
<INVESTMENTS-MARKET>                        3,102,000
<LOANS>                                    13,451,728
<ALLOWANCE>                                    60,000
<TOTAL-ASSETS>                             22,906,700
<DEPOSITS>                                 15,728,150
<SHORT-TERM>                                        0
<LIABILITIES-OTHER>                           596,347
<LONG-TERM>                                         0
<COMMON>                                        4,232
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<OTHER-SE>                                  6,577,971
<TOTAL-LIABILITIES-AND-EQUITY>             22,906,700
<INTEREST-LOAN>                               293,092
<INTEREST-INVEST>                              64,319
<INTEREST-OTHER>                               70,876
<INTEREST-TOTAL>                              428,287
<INTEREST-DEPOSIT>                            198,975
<INTEREST-EXPENSE>                            198,975
<INTEREST-INCOME-NET>                         229,312
<LOAN-LOSSES>                                       0
<SECURITIES-GAINS>                                  0
<EXPENSE-OTHER>                               155,490
<INCOME-PRETAX>                                75,648
<INCOME-PRE-EXTRAORDINARY>                     75,648
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                   48,648
<EPS-PRIMARY>                                    0.12
<EPS-DILUTED>                                    0.11
<YIELD-ACTUAL>                                   7.70
<LOANS-NON>                                         0
<LOANS-PAST>                                        0
<LOANS-TROUBLED>                                    0
<LOANS-PROBLEM>                                     0
<ALLOWANCE-OPEN>                                    0       
<CHARGE-OFFS>                                       0
<RECOVERIES>                                        0
<ALLOWANCE-CLOSE>                              60,000
<ALLOWANCE-DOMESTIC>                           60,000
<ALLOWANCE-FOREIGN>                                 0
<ALLOWANCE-UNALLOCATED>                             0
        

</TABLE>
# C_2020399EN.01003301.xml

| 23.11.2020 | EN | Official Journal of the European Union | C 399/33 |
| --- | --- | --- | --- |

23.11.2020

EN

Official Journal of the European Union

C 399/33

---

Judgment of the General Court of 23 September 2020 — Brillux v EUIPO — Synthesa Chemie (Freude an Farbe)

(Case T-402/19) (1)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Figurative mark Freude an Farbe - Earlier EU figurative mark Glemadur Freude an Farbe - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2020/C 399/47)

Language of the case: German

Parties

Applicant: Brillux GmbH & Co. KG (Münster, Germany) (represented by: R. Schiffer, lawyer)

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Synthesa Chemie GesmbH (Perg, Austria) (represented by: A. Haberl, lawyer)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 29 March 2019 (Case R 1434/2018-5), relating to opposition proceedings between Synthesa Chemie and Brillux.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Brillux GmbH & Co. KG to pay the costs. |
| --- | --- |

2.

Orders Brillux GmbH & Co. KG to pay the costs.

---

(1)  OJ C 288, 26.8.2019.

---